The epidermal growth factor receptor–tyrosine kinase: A promising therapeutic target in solid tumors
- 1 February 2003
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 30 (1), 3-11
- https://doi.org/10.1053/sonc.2003.50027
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Receptor tyrosine kinase signalling as a target for cancer intervention strategies.Endocrine-Related Cancer, 2001
- The EGFR family and its ligands in human cancerEuropean Journal Of Cancer, 2001
- The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification.Endocrine-Related Cancer, 2001
- Untangling the ErbB signalling networkNature Reviews Molecular Cell Biology, 2001
- NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancerThe EMBO Journal, 2000
- Epidermal Growth Factor Receptor Tyrosine Kinase as a Target for Anticancer TherapyDrugs, 2000
- c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptorGenes & Development, 1998
- All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis ImpairedJournal of Biological Chemistry, 1996
- Single-Chain Antibody-Mediated Intracellular Retention of ErbB-2 Impairs Neu Differentiation Factor and Epidermal Growth Factor SignalingMolecular and Cellular Biology, 1995
- Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase C gamma or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members.Molecular and Cellular Biology, 1994